BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq
California-based biotech BioAge Labs will have its initial public offering of stock. The company is developing Azelaprag, a ...
Severe obesity is on the rise in the US
Most telling though, the results that show that the overall obesity rate in the U.S. has not changed significantly in a ...
Clayton News24d
Weight-Loss Drug Zepbound May Work Better in Women Than Men
As a home delivery subscriber, you get free unlimited digital access to news-daily.com including stories, photos, obituaries, e-edition and more on your computer, tablet or phone. All you need is ...
Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound
Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...
Zepbound is no longer in shortage. That could hurt off-brand weight loss drug sellers
The shortage of Eli Lilly’s (LLY) blockbuster diabetes and weight loss drugs is officially over, according to the U.S. Food ...
Yahoo2d
Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound
The popular weight-loss and diabetes medication tirzepatide is no longer in short supply, the Food and Drug Administration said. Eli Lilly's tirzepatide, sold as Zepbound for weight loss and ...
FOX 5 New York on MSN2d
Illegal weight loss drug sales surge on Facebook
Doctors and law enforcement are raising concerns about the growing trend of people selling weight loss drugs like Ozempic and ...
Reuters4d
Lilly's weight-loss drug removed from FDA's shortage list
Diabetes treatment Mounjaro has been on the health regulator's shortage list since late 2022, while weight-loss drug Zepbound was added in April as demand far outstripped supply. The limited ...